MKI67 and neoplasm: The three monotherapies and rapamycin combinations did not cause enhanced tumor cell death (Appendix Fig S13 and Table S5) or alteration of autophagy in vitro (Appendix Fig S14), but tumor cell proliferation decreased as measured by Ki67 immunostaining (Appendix Fig S15).